Literature DB >> 35064418

A New Saquinavir Mesylate-Sodium Decyl Sulfate Salt Discovered by Serendipity during an Anomalous Dissolution Test.

Cinira Fandaruff1, Thiago Caon2, Andrea Mariela Araya-Sibaja3, Gabriela Schneider Rauber4, Marcos Antônio Segatto Silva4, Cláudia Maria Oliveira Simões5, Carlos Eduardo Maduro de Campos6, Adailton João Bortoluzzi7, Jackson Antônio Lamounier Camargos Resende8, Silvia Lucia Cuffini9.   

Abstract

PURPOSE: To understand the anomalous behavior of Saquinavir Mesylate (SQVM) in sodium decyl sulfate (SDS) medium during a dissolution test through a crystallographic analysis of the crystal obtained. As a result, it will be possible to elucidate its crystal structure and carry out a complete solid-state characterization of the API.
METHODS: The solid form obtained was characterized by a structural analysis through X-ray single crystal and powder diffraction. The crystallographic structures of the new salt and the SQVM were compared. In addition, a complete solid-state characterization of SQVM raw material was carried out by techniques such as diffuse reflectance infrared Fourier transform spectroscopy (DRIFTS), Raman spectroscopy, scanning electron microscopy and a dissolution method.
RESULTS: A new salt consisting of SQVM and SDS was crystallized and its crystal structure was elucidated and reported herein for the first time. The anionic part of SDS interacts with the cationic segment of SQVM to obtain a new salt designated as SQV-DS, which precipitates. The main difference between the two structures occurs in the c-axis expansion, which increases from 15.966 (5) to 21.1924 (14), respectively.
CONCLUSIONS: Some of the strategies to enhance the dissolution rate of poorly aqueous soluble APIs include the use of surfactants such as SDS in the dissolution medium, as well as in the formulated products. However, there have been constant reports of a dissolution rate slowdown by some surfactants. The interaction mechanisms between the APIs and the dissolution medium containing surfactants need to be carefully investigated in current pharmaceutical formulations. Graphical Abstract.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  dissolution; recrystallization; saquinavir mesylate; single crystal; sodium decyl sulfate

Mesh:

Substances:

Year:  2022        PMID: 35064418     DOI: 10.1007/s11095-022-03167-4

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  5 in total

1.  Correlation between microstructure and bioequivalence in anti-HIV drug efavirenz.

Authors:  Cinira Fandaruff; Marcos Antônio Segatto Silva; Danilo Cesar Galindo Bedor; Davi Pereira de Santana; Helvécio Vinícius Antunes Rocha; Luca Rebuffi; Cristy Leonor Azanza Ricardo; Paolo Scardi; Silvia Lucia Cuffini
Journal:  Eur J Pharm Biopharm       Date:  2015-02-03       Impact factor: 5.571

2.  Efavirenz dissolution enhancement III: Colloid milling, pharmacokinetics and electronic tongue evaluation.

Authors:  Cristiane R D Hoffmeister; Cinira Fandaruff; Maíra A da Costa; Lucio M Cabral; Luciana R Pitta; Stanley E R Bilatto; Livia D Prado; Daniel S Corrêa; Leandro Tasso; Marcos Antônio S Silva; Helvécio V A Rocha
Journal:  Eur J Pharm Sci       Date:  2016-12-29       Impact factor: 4.384

3.  Mechanism of transport of saquinavir-loaded nanostructured lipid carriers across the intestinal barrier.

Authors:  Ana Beloqui; María Ángeles Solinís; Alicia R Gascón; Ana del Pozo-Rodríguez; Anne des Rieux; Véronique Préat
Journal:  J Control Release       Date:  2012-12-22       Impact factor: 9.776

4.  Development and physicochemical characterization of saquinavir mesylate solid dispersions using Gelucire 44/14 or PEG 4000 as carrier.

Authors:  Thiago Caon; Ricardo Augusto Konig; Ariadne Cristiane Cabral da Cruz; Simone Gonçalves Cardoso; Carlos Eduardo Maduro Campos; Silvia Lucia Cuffini; Letícia Scherer Koester; Cláudia Maria Oliveira Simões
Journal:  Arch Pharm Res       Date:  2013-05-23       Impact factor: 4.946

Review 5.  Insoluble drug delivery strategies: review of recent advances and business prospects.

Authors:  Sandeep Kalepu; Vijaykumar Nekkanti
Journal:  Acta Pharm Sin B       Date:  2015-08-24       Impact factor: 11.413

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.